Patents by Inventor Eun Kyeong KIM
Eun Kyeong KIM has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 10421779Abstract: The present invention relates to a carbazole compound having anti-virus activity, and more particularly, to a novel compound selected from the group of consisting of a carbazole compound which shows excellent anti-proliferative efficacy against hepatitis C virus (HCV), a pharmaceutically acceptable salt thereof, a hydrate thereof, and an isomer thereof; an anti-virus pharmaceutical composition including the novel compound as an active ingredient; a pharmaceutical composition for preventing or treating liver diseases caused by hepatitis C virus; and a method of preparing the novel compound.Type: GrantFiled: August 25, 2017Date of Patent: September 24, 2019Assignees: KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY, POSTECH ACADEMY-INDUSTRY FOUNDATIONInventors: Gyo Chang Keum, Eunice Eun Kyeong Kim, Sung Key Jang, Hee Sun Kim, Ae Nim Pae, Hua Li, Jin Hyeong Park, Jin Sook Kwak
-
Publication number: 20180057527Abstract: The present invention relates to a carbazole compound having anti-virus activity, and more particularly, to a novel compound selected from the group of consisting of a carbazole compound which shows excellent anti-proliferative efficacy against hepatitis C virus (HCV), a pharmaceutically acceptable salt thereof, a hydrate thereof, and an isomer thereof; an anti-virus pharmaceutical composition including the novel compound as an active ingredient; a pharmaceutical composition for preventing or treating liver diseases caused by hepatitis C virus; and a method of preparing the novel compound.Type: ApplicationFiled: August 25, 2017Publication date: March 1, 2018Applicants: KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY, POSTECH ACADEMY-INDUSTRY FOUNDATIONInventors: Gyo Chang KEUM, Eunice Eun Kyeong KIM, Sung Key JANG, Hee Sun KIM, Ae Nim PAE, Hua LI, Jin Hyeong PARK, Jin Sook KWAK
-
Oxazolidinone derivatives and composition for preventing or treating hepatitis C containing the same
Patent number: 9422274Abstract: The present invention relates to oxazolidinone compounds represented by Chemical Formula 1, pharmaceutically acceptable salts thereof or hydrates, a method of preparing the same, and a pharmaceutical composition for preventing or treating Hepatitis C infection: Wherein R1, R7 and X are defined in the detailed description.Type: GrantFiled: November 12, 2014Date of Patent: August 23, 2016Assignee: KOREA INSTITUTE OF SCIENCE AND TECHNOLOGYInventors: Sung Key Jang, Gyo Chang Keum, Eunice Eun-Kyeong Kim, Soon Bang Kang, Suyeon Yeom, Juhyeon Lee, SeungGi Lee, Hee Sun Kim -
Oxazolidinone derivatives and composition for preventing or treating Hepatitis C containing the same
Publication number: 20150148386Abstract: The present invention relates to oxazolidinone compounds represented by Chemical Formula 1, pharmaceutically acceptable salts thereof or hydrates, a method of preparing the same, and a pharmaceutical composition for preventing or treating Hepatitis C infection: Wherein R1, R7 and X are defined in the detailed description.Type: ApplicationFiled: November 12, 2014Publication date: May 28, 2015Applicants: POSTECH ACADEMY-INDUSTRY FOUNDATION, KOREA INSTITITE OF SCIENCE AND TECHNOLOGYInventors: Sung Key JANG, GYO CHANG KEUM, Eunice Eun-Kyeong KIM, Soon Bang KANG, Suyeon YEOM, Juhyeon LEE, SeongGi LEE, HEE SUN KIM -
Patent number: 9012481Abstract: Novel benzoarylureido compounds and a use thereof for prevention and/or treatment of the neurodegenerative brain disease are provided. The neurodegenerative brain diseases may include Alzheimer's disease, dementia, Parkinson's disease, stroke, amyloidosis, Pick's disease, Lou Gehrig's disease, Huntington's disease, Creutzfeld-Jakob disease, and the like.Type: GrantFiled: December 29, 2009Date of Patent: April 21, 2015Assignee: Korea Institute of Science and TechnologyInventors: Hoh-Gyu Hahn, Kee-Dal Nam, Dong-Yun Shin, Chan-Ho Park, Sung-Woo Cho, Eun-A Kim, Ghil-Soo Nam, Kyung-Il Chol, Seon-Hee Seo, Hee-Sup Shin, Dong-Jin Kim, Ae-Nim Pae, Hye-Jin Chung, Hyun-Ah Choo, Hye-Whon Rhim, Yong-Seo Cho, Eun-Joo Roh, Gyo-Chang Keum, Kee-Hyun Choi, Kye-Jung Shin, Chan-Seong Cheong, Jae-Kyun Lee, Yong-Koo Kang, Young-Soo Kim, Woong-Seo Park, Key-Sun Kim, He-Sson Chung, Chi-Man Song, Sun-Joon Min, Eunice Eun-Kyeong Kim, Cheol-Ju Lee, Soon-Bang Kang
-
Patent number: 8865852Abstract: A low-dielectric constant thin film prepared from a silsesquioxane polymer matrix as a precursor and a method for preparing the same which comprises preparing silsesquioxane sol by adding a stereoisomer of a multi reactive cyclosiloxane to an alkoxysilane are provided. The low-dielectric-constant thin film retains a stable film state even at a curing temperature of ?500° C. without being decomposed, a very uniform surface property with a low surface modulus, and a superior coatability as to be coatable smoothly with no crack even with a thickness of 500 nm or larger.Type: GrantFiled: October 21, 2010Date of Patent: October 21, 2014Assignee: Korea Institute of Science and TechnologyInventors: Kyung Youl Baek, Seung Sang Hwang, Seung-Sock Choi, Sungyoun Oh, He Seung Lee, Eun Kyeong Kim
-
Patent number: 8507540Abstract: The present invention relates to oxazolidinone derivatives containing new bicyclic group, having antibacterial activity, or a pharmaceutically acceptable salt thereof, a method for preparing the same, an antibacterial composition comprising the oxazolidinone derivative or a pharmaceutically acceptable salt thereof as an active ingredient, and a method for treating an infectious disease caused by pathogen using the same. The oxazolidinone derivative or a pharmaceutically acceptable salt thereof may exhibit excellent antibacterial activity against gram positive bacteria including various resistant strains.Type: GrantFiled: December 8, 2011Date of Patent: August 13, 2013Assignee: Korean Institute of Science and TechnologyInventors: Gyo-Chang Keum, Eunice Eun-Kyeong Kim, Ae-Nim Pae, Kyung-Il Choi, Soon-Bang Kang, Seon-Hee Seo, Deepak Bhattaral, Ju-Hyeon Lee
-
Patent number: 8492384Abstract: Disclosed are novel imidazolylalkylcarbonyl derivatives useful as calcium channel modulators and a preparation method of the same. Also disclosed is a method for the treatment of diseases by administering the above compounds based on their inhibitory activity against calcium channel.Type: GrantFiled: June 26, 2009Date of Patent: July 23, 2013Assignee: Korea Institute of Science and TechnologyInventors: Kyung Il Choi, Ghilsoo Nam, Hye Ran Kim, Hyewhon Rhim, Seon Hee Seo, Yoon Jee Kim, Hee Sup Shin, Dong Jin Kim, Ae Nim Pae, Hye Jin Chung, Yong Seo Cho, Hyunah Choo, Eun Joo Roh, Soon Bang Kang, Kye Jung Shin, Hoh Gyu Hahn, Dong Yun Shin, Chan Seong Cheong, Kee Dal Nam, Yong Koo Kang, Jae Kyun Lee, Woong Seo Park, Youngsoo Kim, Eunice Eun-Kyeong Kim, Key-Sun Kim, Hesson Chung, Gyo Chang Keum, Cheolju Lee, Kee Hyun Choi
-
Publication number: 20130012554Abstract: The present invention relates to oxazolidinone derivatives containing new bicyclic group, having antibacterial activity, or a pharmaceutically acceptable salt thereof, a method for preparing the same, an antibacterial composition comprising the oxazolidinone derivative or a pharmaceutically acceptable salt thereof as an active ingredient, and a method for treating an infectious disease caused by pathogen using the same. The oxazolidinone derivative or a pharmaceutically acceptable salt thereof may exhibit excellent antibacterial activity against gram positive bacteria including various resistant strains.Type: ApplicationFiled: December 8, 2011Publication date: January 10, 2013Applicant: Korean Institute of Science and TechnologyInventors: Gyo-Chang KEUM, Eunice Eun-Kyeong Kim, Ae-Nim Pae, Kyung-II Choi, Soon-Bang Kang, Seon-Hee Seo, Deepak Bhattaral, Ju-Hyeon Lee
-
Patent number: 8299072Abstract: The present invention relates to pyrazolylmethylamine-piperazine derivatives and their pharmaceutically acceptable salts effective as calcium channel modulators and a method of manufacturing the same. The present invention also relates to the medicinal use of the above compounds as therapeutic treatment of diseases due to their effect as calcium channel modulators.Type: GrantFiled: September 28, 2009Date of Patent: October 30, 2012Assignee: Korea Institute of Science and TechnologyInventors: Ghilsoo Nam, Kyung Il Choi, Hye Ran Kim, Seon Hee Seo, Yoon Jee Kim, Hee Sup Shin, Dong Jin Kim, Ae Nim Pae, Hye Jin Chung, Hyunah Choo, Hyewhon Rhim, Yong Seo Cho, Eun Joo Roh, Gyo Chang Keum, Kee Hyun Choi, Kye Jung Shin, Hoh Gyu Hahn, Chan Seong Cheong, Jae Kyun Lee, Kee Dal Nam, Yong Koo Kang, Youngsoo Kim, Woong Seo Park, Eunice Eun-Kyeong Kim, Key-Sun Kim, Hesson Chung, Dong Yun Shin, Chi man Song
-
Publication number: 20120004368Abstract: Disclosed are a low-dielectric-constant thin film prepared from a silsesquioxane polymer matrix as a precursor, the silsesquioxane polymer matrix being a silsesquioxane sol prepared by adding a stereoisomer of a multireactive cyclosiloxane to an alkoxysilane, and a method for preparing the same. The disclosed low-dielectric-constant thin film retains a stable film state even at a curing temperature of ˜500° C. without being decomposed. Also, it exhibits a very uniform surface property with a low surface modulus and has such a superior coatability as to be coatable smoothly with no crack even with a thickness of 500 nm or larger. In addition, the low-dielectric-constant thin film according to the present disclosure may exhibit low dielectric property while having superior surface modulus and hardness.Type: ApplicationFiled: October 21, 2010Publication date: January 5, 2012Applicant: KOREA INSTITUTE OF SCIENCE AND TECHNOLOGYInventors: Kyung Youl BAEK, Seung Sang HWANG, Seung-Sock CHOI, SUNGYOUN OH, He Seung LEE, Eun Kyeong KIM
-
Publication number: 20110319456Abstract: Novel benzoarylureido compounds and a use thereof for prevention and/or treatment of the neurodegenerative brain disease are provided. The neurodegenerative brain diseases may include Alzheimer's disease, dementia, Parkinson's disease, stroke, amyloidosis, Pick's disease, Lou Gehrig's disease, Huntington's disease, Creutzfeld-Jakob disease, and the like.Type: ApplicationFiled: December 29, 2009Publication date: December 29, 2011Applicant: KOREA INSTITUTE OF SCIENCE AND TECHNOLOGYInventors: Hoh-Gyu Hahn, Kee-Dal Nam, Dong-Yun Shin, Chan-Ho Park, Sung-Woo Cho, Eun-A Kim, Ghil-Soo Nam, Kyung-Il Chol, Seon-Hee Seo, Hee-Sup Shin, Dong-JIn Kim, Ae-Nim Pae, Hye-JIn Chung, Hyun-Ah Choo, Hye-Whon Rhim, Yong-Seo Cho, Eun-Jon Roh, Gyo-Chang Keum, Kee-Hyun Choi, Kye-Jung Shin, Chan-Seong Cheong, Jae-Kyun Lee, Yong-Koo Kang, Young-Soo Kim, Woong-Seo Park, Key-Sun Kim, He-Sson Chung, Chi-Man Song, Sun-Joon Min, Eunlce Eun-Kyeong Kim, Cheol-Ju Lee, Soon-Bang Kang
-
Patent number: 7797112Abstract: The present invention relates to a FabK (enoyl-acyl carrier protein reductase) protein derived from a Thermotoga maritima strain. In the present invention, the active site and the three-dimensional crystal structure of the protein are determined, a novel inhibitor against the FabK protein is screened and/or designed using the three-dimensional crystal structure thereof, and thereby developing a novel active compound, namely active-controlling material with excellent antibiotic activities against strains having a resistance to previous antibiotics.Type: GrantFiled: December 28, 2007Date of Patent: September 14, 2010Assignee: Korea Institute of Science and TechnologyInventors: Eunice Eun-Kyeong Kim, Byung Hak Ha
-
Publication number: 20100094006Abstract: The present invention relates to pyrazolylmethylamine-piperazine derivatives and their pharmaceutically acceptable salts effective as calcium channel modulators and a method of manufacturing the same. The present invention also relates to the medicinal use of the above compounds as therapeutic treatment of diseases due to their effect as calcium channel modulators.Type: ApplicationFiled: September 28, 2009Publication date: April 15, 2010Inventors: Ghilsoo NAM, Kyung Il Choi, Hye Ran Kim, Seon Hee Seo, Yoon Jee Kim, Hee Sup Shin, Dong Jin Kim, Ae Nim Pae, Hye Jin Chung, Hyunah Choo, Hyewhon Rhim, Yong Seo Cho, Eun Joo Roh, Gyo Chang Keum, Kee Hyun Choi, Kye Jung Shin, Hoh Gyu Hahn, Chan Seong Cheong, Jae Kyun Lee, Kee Dal Nam, Yong Koo Kang, Youngsoo Kim, Woong Seo Park, Eunice Eun-Kyeong Kim, Key-Sun Kim, Hesson Chung, Dong Yun Shin, Chi man Song
-
Publication number: 20100004286Abstract: Disclosed are isoindolinone derivatives, represented by Chemical Formula 1, having inhibitory activity against T-type calcium channels, pharmaceutically acceptable salts thereof, a preparation method thereof, and a pharmaceutical composition comprising the same as an active ingredient. wherein R1˜R6 are as defined in the specification.Type: ApplicationFiled: October 23, 2008Publication date: January 7, 2010Applicant: KOREA INSTITUTE OF SCIENCE AND TECHNOLOGYInventors: Yong Seo CHO, Ae Nim PAE, Hyunah CHOO, Jae Kyun LEE, You Na OH, Hee Sup SHIN, Dong Jin KIM, Hoh Gyu HAHN, Kyung Il CHOI, Ghilsoo NAM, Kye Jung SHIN, Soon Bang KANG, Eun Joo ROH, Dong Yun SHIN, Seon Hee SEO, Hyewhon RHIM, Gyo Chang KEUM, Key-Sun KIM, Chan Seong CHEONG, Eunice Eun-Kyeong KIM, Cheolju LEE, Youngsoo KIM, Kee Hyun CHOI, Kee Dal NAM, Woong Seo PARK, Yong Koo KANG, Hye Jin CHUNG
-
Publication number: 20090325979Abstract: Disclosed are novel imidazolylalkylcarbonyl derivatives useful as calcium channel modulators and a preparation method of the same. Also disclosed is a method for the treatment of diseases by administering the above compounds based on their inhibitory activity against calcium channel.Type: ApplicationFiled: June 26, 2009Publication date: December 31, 2009Inventors: Kyung Il CHOI, Ghilsoo Nam, Hye Ran Kim, Hyewhon Rhim, Seon Hee Seo, Yoon Jee Kim, Hee Sup Shin, Dong Jin Kim, Ae Nim Pae, Hye Jin Chung, Yong Seo Cho, Hyunah Choo, Eun Joo Roh, Soon Bang Kang, Kye Jung Shin, Hoh Gyu Hahn, Dong Yun Shin, Chan Seong Cheong, Kee Dal Nam, Yong Koo Kang, Jae Kyun Lee, Woong Seo Park, Youngsoo Kim, Eunice Eun-Kyeong Kim, Key-Sun Kim, Hesson Chung, Gyo Chang Keum, Cheolju Lee, Kee Hyun Choi
-
Publication number: 20090170117Abstract: The present invention relates to a FabK (enoyl-acyl carrier protein reductase) protein derived from a Thermotoga maritima strain. In the present invention, the active site and the three-dimensional crystal structure of the protein are determined, a novel inhibitor against the FabK protein is screened and/or designed using the three-dimensional crystal structure thereof, and thereby developing a novel active compound, namely active-controlling material with excellent antibiotic activities against strains having a resistance to previous antibiotics.Type: ApplicationFiled: December 28, 2007Publication date: July 2, 2009Applicant: KOREA INSTITUTE OF SCIENCE AND TECHNOLOGYInventors: Eunice Eun-Kyeong KIM, Byung-Hak HA
-
Patent number: 6747050Abstract: The present invention provides to an isoxazoline derivative of formula (I), the pharmaceutically acceptable salts, esters and stereochemically isomeric forms thereof, and the use of the derivative in inhibiting the activity of caspases. The present invention also provides a pharmaceutical composition for preventing inflammation and apoptosis which comprise the isoxazoline derivative, pharmaceutically acceptable salts, esters and stereochemically isomeric forms thereof and the process for preparing the same. The derivative according to the present invention can be effectively used in treating diseases due to caspases, such as, for example the disease in which cells are abnormally died, dementia, cerebral stroke, AIDS, diabetes, gastric ulcer, hepatic injury by hepatitis, sepsis, organ transplantation rejection reaction and anti-inflammation.Type: GrantFiled: March 15, 2002Date of Patent: June 8, 2004Assignee: LG Chem Investment Ltd.Inventors: Eunice Eun-Kyeong Kim, Mi-Jeong Park, Tae-Hee Lee, Hye-Kyung Chang, Tae-Kyo Park, Chang-Yuil Kang, Young-Myeong Kim, Kwang-Yul Moon, Young-Leem Oh, Chang-Hee Min, Hyun-Ho Chung
-
Patent number: 6683095Abstract: A novel 3-hydroxychromen-4-one derivative, pharmaceutically acceptable salt, hydrate, solvate or isomer thereof which is useful as an inhibitor for Cyclin Dependent Kinase (“CDK”) is disclosed. Further, a process for preparing the compound and a composition for suppression or treatment of cancer and diseases induced by cell proliferation such as inflammation, angiostenosis, angiogenesis, etc. is disclosed comprising the compound as an active component together with pharmaceutically acceptable carriers.Type: GrantFiled: November 1, 2002Date of Patent: January 27, 2004Assignee: LG Life Sciences Ltd.Inventors: Chang-Yong Hong, Jin-Ho Lee, Tae-Sik Park, Jong-Hyun Kim, Sei-Hyun Choi, Sook-Kyung Yoon, Hyun-Ho Chung, Ho-Sun Son, Eunice Eun-Kyeong Kim, Seong-Gu Ro, Shin-Wu Jeong, Dong-Myung Kim
-
Publication number: 20030125356Abstract: The present invention relates to a novel 3-hydroxychromen-4-one derivative of formula (1), pharmaceutically acceptable salt, hydrate, solvate or isomer thereof which is useful as an inhibitor for Cyclin Dependent Kinase (“CDK”); to a process for preparing the compound of formula (1); and to a composition for suppression or treatment of cancer and diseases induced by cell proliferation such as inflammation, angiostenosis, angiogenesis, etc. comprising the compound of formula (1) as an active component together with pharmaceutically acceptable carriers.Type: ApplicationFiled: November 1, 2002Publication date: July 3, 2003Inventors: Chang-Yong Hong, Jin-Ho Lee, Tae-Sik Park, Jong-Hyun Kim, Sei-Hyun Choi, Sook-Kyung Yoon, Hyun-Ho Chung, Ho-Sun Son, Eunie Eun-Kyeong Kim, Seong-Gu Ro, Shin-Wu Jeong, Dong-Myung Kim